drugset / Trial / NCT07185594
A Phase Ⅱ/Ⅲ Study of HRS-2129 for Postsurgical Pain Management in Abdominal Surgery
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a phase II/III, multi-center, randomized, double-blind, comparator-controlled study to evaluate the efficacy and safety of HRS-2129 for postoperative pain management in abdominal surgery.
Timeline
- Start
- 2025-10-24
- Primary completion
- 2025-12
- Completion
- 2026-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-2129 | Unknown | — | — |
| Comparator | Tramadol | Other / unclassified | — | — |
Indications
No indication recorded.